EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Multi‐pronged analysis of pediatric low‐grade glioma and ganglioglioma reveals a unique tumor microenvironment associated with BRAF alterations

Shadi Zahedi iD, Kent Riemondy, Tian Liu, Andrea M Griesinger, Andrew M Donson, April A Apfelbaum, Rui Fu, Julian Grandvallet Contreras iD, Michele Crespo, John DeSisto, Madeline M Groat, Emil Bratbak und 8 weitere

Brain Pathology · 2025

DOI: 10.1111/bpa.70023 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain Pathology, 2025. Verfasst von Shadi Zahedi und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA. Hauptthemen laut MEDLINE: Tumor Microenvironment, Proto-Oncogene Proteins B-raf, Ganglioglioma, Brain Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Morgan Adams Foundations, Amazon Goes Gold for Kids with Cancer, Peter Barton Family Fund for Clinical and Translational Cancer Research at The Children's Hospital Colorado Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pediatric low‐grade gliomas (pLGG) comprise 35% of all brain tumors. Despite favorable survival, patients experience significant morbidity from disease and treatments. A deeper understanding of pLGG biology is essential to identify novel, more effective, and less toxic therapies. We utilized single‐cell RNA sequencing (scRNA‐seq), spatial transcriptomics, and cytokine analyses to characterize and understand tumor and immune cell heterogeneity of pilocytic astrocytoma (PA) and ganglioglioma (GG). scRNA‐seq revealed tumor and immune cells within the tumor microenvironment (TME). Tumor cell subsets include both progenitor and mature cell populations. Immune cells included myeloid and lymphocytic cells. There was a significant difference between the prevalence of two major myeloid subclusters between PA and GG. Bulk and single‐cell cytokine analyses evaluated the immune cell signaling cascade with distinct immune phenotypes among tumor samples. KIAA1549‐BRAF tumors appeared more immunogenic, secreting higher levels of immune cell activators and chemokines, compared to BRAF V600E tumors. Spatial transcriptomics revealed the differential gene expression of these chemokines and their location within the TME. A multi‐pronged analysis demonstrated the complexity of the PA and GG TME and differences between genetic drivers that may influence their response to immunotherapy. Further investigation of immune cell infiltration and tumor‐immune interactions is warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentProto-Oncogene Proteins B-rafGangliogliomaBrain NeoplasmsGliomaHumansChildFemaleMaleChild, PreschoolAdolescentTranscriptomeAstrocytomaMutation

Stichwörter der Autor:innen

Pilocytic astrocytomachemokinegangliogliomascRNA‐sequencingspatial transcriptomics

Substanzen

Proto-Oncogene Proteins B-rafBRAF protein, human

Autor:innen und Institutionen

  • Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
  • Department of Pediatrics, Morgan Adams Foundation Pediatric Brain Tumor Research Program, Children's Hospital Colorado, Aurora, Colorado, USA.
  • Clinical Science Program, Graduate School, Anschutz Medical Campus, University of Colorado, Denver, Colorado, USA.
  • RNA Bioscience Initiative, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
  • Department of Pediatric Oncology, Broad Institute Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Dana-Farber Cancer/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA.
  • Department of Pediatrics, Harvard Medical School, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.

ORCID-Profile: Shadi Zahedi, Julian Grandvallet Contreras, Todd C Hankinson, Jean Mulcahy Levy

Förderung

  • the Morgan Adams Foundations
  • Amazon Goes Gold for Kids with Cancer
  • Peter Barton Family Fund for Clinical and Translational Cancer Research at The Children's Hospital Colorado Foundation
  • University of Colorado Cancer Center Support
  • NCI NIH HHS
  • Olivia Caldwell Foundation
  • Alex's Lemonade Stand Foundation for Childhood Cancer
  • NCATS NIH HHS

Zitieren

APA

Zahedi, S., Riemondy, K., Liu, T., Griesinger, A. M., Donson, A. M., Apfelbaum, A. A., Fu, R., Grandvallet Contreras, J., Crespo, M., DeSisto, J., Groat, M. M., Bratbak, E., Green, A., Hankinson, T. C., Handler, M., Vibhakar, R., Willard, N., Foreman, N. K., Phang, T., & Mulcahy Levy, J. (2025). Multi‐pronged analysis of pediatric low‐grade glioma and ganglioglioma reveals a unique tumor microenvironment associated with BRAF alterations. Brain Pathology. https://doi.org/10.1111/bpa.70023

Vancouver

Zahedi S, Riemondy K, Liu T, Griesinger AM, Donson AM, Apfelbaum AA, et al. Multi‐pronged analysis of pediatric low‐grade glioma and ganglioglioma reveals a unique tumor microenvironment associated with BRAF alterations. Brain Pathology. 2025. doi:10.1111/bpa.70023

BibTeX
@article{Zahedi2025,
  author = {Zahedi, Shadi and Riemondy, Kent and Liu, Tian and Griesinger, Andrea M and Donson, Andrew M and Apfelbaum, April A and Fu, Rui and Grandvallet Contreras, Julian and Crespo, Michele and DeSisto, John and Groat, Madeline M and Bratbak, Emil and Green, Adam and Hankinson, Todd C and Handler, Michael and Vibhakar, Rajeev and Willard, Nicholas and Foreman, Nicholas K and Phang, Tzu and Mulcahy Levy, Jean},
  title = {Multi‐pronged analysis of pediatric low‐grade glioma and ganglioglioma reveals a unique tumor microenvironment associated with BRAF alterations},
  journal = {Brain Pathology},
  year = {2025},
  doi = {10.1111/bpa.70023}
}
Kostenlos starten →